Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Duopharma Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

RM931.7 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

MYRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue498.7M576.5M569.9M639.2M696.7M704.7M813.7M931.7M
Cost of goods sold258.0M317.5M307.6M353.2M380.7M393.4M466.8M513.5M
Gross profit241.8M260.2M262.9M287.5M316.1M311.7M347.0M418.5M
Gross profit margin, %45.1%46.1%45.0%45.4%44.2%42.6%44.9%
Operating expense total149.7M156.0M152.8M166.7M186.7M185.8M202.1M228.1M
Depreciation and amortization24.7M26.9M29.1M32.0M36.2M43.1M45.4M55.0M
EBITDA92.1M104.2M110.1M120.8M129.4M125.9M144.8M190.4M
EBITDA margin, %18.1%19.3%18.9%18.6%17.9%17.8%20.4%
EBIT67.4M77.7M81.0M88.9M93.2M82.8M99.8M135.3M
EBIT margin, %13.5%14.2%13.9%13.4%11.8%12.3%14.5%
Interest income2.1M1.5M1.5M1.2M1.5M2.8M6.0M5.9M
Interest expense7.7M8.3M7.2M7.0M9.6M18.2M26.6M24.8M
Pre tax profit59.7M70.8M76.2M83.0M84.9M63.3M80.0M114.9M
Income tax expense12.0M15.5M17.5M17.3M14.7M10.6M17.4M27.4M
Net Income47.6M55.3M58.6M65.7M70.1M52.6M62.6M87.5M

Footer menu